Bessemer Venture Partners — KYMR
How Bessemer Venture Partners's position in Kymera Therapeutics, Inc. changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing.
- Quarters held
- 20
- First reported
- Q4 2021
- Latest value
- $14,073,802
- Latest weight
- 1.8%
- Peak weight
- 3.1%
- Shares since first
- -79.6%
Position Trend
Shares, value, and weight from first report to latest report.
Bessemer Venture Partners first reported 615,895 shares in Q4 2021 and most recently reported 125,895 shares in Q3 2026. Portfolio weight peaked at 3.1% in Q3 2024; the low reported weight was 0.8% in Q2 2022.
Since the first report, shares are -79.6% and reported value is -64%. Latest move: —
| Quarter | Shares | Value | % of portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | 125,895 | $14,073,802 | 1.76% | — |
| Q2 2026 | 125,895 | $14,436,380 | 1.78% | — |
| Q1 2026 | 125,895 | $10,485,795 | 1.69% | TRIM |
| Q4 2025 | 230,811 | $17,959,404 | 1.75% | TRIM |
| Q3 2025 | 325,895 | $18,445,657 | 1.65% | — |
| Q2 2025 | 325,895 | $14,222,058 | 1.13% | TRIM |
| Q1 2025 | 415,895 | $11,383,046 | 1.05% | — |
| Q4 2024 | 415,895 | $16,731,456 | 1.31% | — |
| Q3 2024 | 415,895 | $19,684,310 | 3.12% | — |
| Q2 2024 | 415,895 | $12,414,466 | 2.55% | — |
| Q1 2024 | 415,895 | $16,718,979 | 3.03% | TRIM |
| Q4 2023 | 615,895 | $15,680,687 | 2.03% | — |
| Q3 2023 | 615,895 | $8,560,941 | 1.04% | — |
| Q2 2023 | 615,895 | $14,159,426 | 1.27% | — |
| Q1 2023 | 615,895 | $18,248,969 | 1.67% | — |
| Q4 2022 | 615,895 | $15,372,739 | 1.42% | — |
| Q3 2022 | 615,895 | $13,408,000 | 0.94% | — |
| Q2 2022 | 615,895 | $12,127,000 | 0.78% | — |
| Q1 2022 | 615,895 | $26,065,000 | 0.9% | — |
| Q4 2021 | 615,895 | $39,103,000 | 1.0% | Newly reported |